Phosphoinositides and cardiovascular diseases

Current Topics in Microbiology and Immunology

Volumn 362, Issue , 2012, Pages 43-60

  Ghigo, Alessandra ^a   Perino, Alessia ^a   Hirsch, Emilio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL TRISPHOSPHATE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; POTASSIUM CHANNEL; RYANODINE RECEPTOR;

ARRHYTHMOGENESIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HYPERTROPHY; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 84870026944     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-5025-8_2     Document Type: Article

References (96)

1. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW 2nd (1998) Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 95:10140-10145
2. Azuma T, Koths K, Flanagan L, Kwiatkowski D (2000) Gelsolin in complex with phosphatidylinositol 4, 5-bisphosphate inhibits caspase-3 and-9 to retard apoptotic progression. J Biol Chem 275:3761-3766
3. Barac YD, Zeevi-Levin N, Yaniv G, Reiter I, Milman F, Shilkrut M, Coleman R, Abassi Z, Binah O (2005) The 1, 4, 5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res 68:75-86
4. Bellocq C, Van Ginneken AC, Bezzina CR, Alders M, Escande D, Mannens MM, Baro I, Wilde AA (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109:2394-2397
5. Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198-205
6. Bian JS, McDonald TV (2007) Phosphatidylinositol 4, 5-bisphosphate interactions with the HERG K (+) channel. Pflugers Arch 455:105-113
7. Bian J, Cui J, McDonald TV (2001) HERG K (+) channel activity is regulated by changes in phosphatidyl inositol 4, 5-bisphosphate. Circ Res 89:1168-1176
8. Bian JS, Kagan A, McDonald TV (2004) Molecular analysis of PIP2 regulation of HERG and IKr. Am J Physiol Heart Circ Physiol 287:H2154-H2163
9. Bristow MR (1998) Why does the myocardium fail? insights from basic science. Lancet 352(Suppl 1): SI8-SI14
10. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergicreceptor density in failing human hearts. N Engl J Med 307:205-211
11. Canobbio I, Stefanini L, Cipolla L, Ciraolo E, Gruppi C, Balduini C, Hirsch E, Torti M (2009) Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM-and integrinmediated signaling in platelets. Blood 114:2193-2196
12. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657
13. Cha TJ, Ehrlich JR, Chartier D, Qi XY, Xiao L, Nattel S (2006) Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation 113:1730-1737
14. Chang JD, Sukhova GK, Libby P, Schvartz E, Lichtenstein AH, Field SJ, Kennedy C, Madhavarapu S, Luo J, Wu D, Cantley LC (2007) Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Proc Natl Acad Sci U S A 104:8077-8082
15. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W (2003) KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299:251-254
16. Consonni A, Cipolla L, Guidetti G, Canobbio I, Ciraolo E, Hirsch E, Falasca M, Okigaki M, Balduini C, Torti M (2012) Role and regulation of phosphatidylinositol 3-kinase beta in platelet integrin alpha2beta1 signaling. Blood 119:847-856
17. Costa C, Barberis L, Ambrogio C, Manazza AD, Patrucco E, Azzolino O, Neilsen PO, Ciraolo E, Altruda F, Prestwich GD, Chiarle R, Wymann M, Ridley A, Hirsch E (2007) Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma. Proc Natl Acad Sci U S A 104:14354-14359
18. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-Dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM (2002) Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110:737-749
19. Czech MP (2000) PIP2 and PIP3: complex roles at the cell surface. Cell 100:603-606
20. Damilano F, Perino A, Hirsch E (2010) PI3K kinase and scaffold functions in heart. Ann N Y Acad Sci 1188:39-45
21. Damilano F, Franco I, Perrino C, Schaefer K, Azzolino O, Carnevale D, Cifelli G, Carullo P, Ragona R, Ghigo A, Perino A, Lembo G, Hirsch E (2011) Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase gamma activity in pressure overload-induced cardiac failure. Circulation 123:391-399
22. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW 2nd (1997) Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 94:8121-8126
23. Domeier TL, Zima AV, Maxwell JT, Huke S, Mignery GA, Blatter LA (2008) IP3 receptordependent Ca2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 294:H596-H604
24. Dorn GW 2nd, Force T (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115:527-537
25. Fougerat A, Gayral S, Gourdy P, Schambourg A, Ruckle T, Schwarz MK, Rommel C, Hirsch E, Arnal JF, Salles JP, Perret B, Breton-Douillon M, Wymann MP, Laffargue M (2008) Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 117:1310-1317
26. Fougerat A, Gayral S, Malet N, Briand-Mesange F, Breton-Douillon M, Laffargue M (2009) Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis? Clin Sci (Lond) 116:791-804
27. Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58:88-111
28. Ghigo A, Morello F, Perino A, Damilano F, Hirsch E (2011) Specific PI3K isoform modulation in heart failure: lessons from transgenic mice. Curr Heart Fail Rep 8:168-175
29. Haider S, Tarasov AI, Craig TJ, Sansom MS, Ashcroft FM (2007) Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis. EMBO J 26:3749-3759
30. Hamilton CA, Thorin E, McCulloch J, Dominiczak MH, Reid JL (1994) Chronic exposure of bovine aortic endothelial cells to native and oxidized LDL modifies phosphatidylinositol metabolism. Atherosclerosis 107:55-63
31. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287:1049-1053
32. Hirsch E, Lembo G, Montrucchio G, Rommel C, Costa C, Barberis L (2006) Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb Haemost 95:29-35
33. Hishikawa K, Nakaki T, Marumo T, Hayashi M, Suzuki H, Kato R, Saruta T (1994) Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin Invest 93:1975-1980
34. Hommers LG, Lohse MJ, Bunemann M (2003) Regulation of the inward rectifying properties of G-protein-activated inwardly rectifying K+ (GIRK) channels by Gbeta gamma subunits. J Biol Chem 278:1037-1043
35. Huang CL, Feng S, Hilgemann DW (1998) Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 391:803-806
36. Ishikawa Y, Asaoka Y, Taniguchi T, Tsunemitsu M, Fukuzaki H (1989) Phosphatidylinositol turnover in human monocyte-derived macrophages by native and acetyl LDL. FEBS Lett 246:35-38
37. Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, Sturgeon SA, Prabaharan H, Thompson PE, Smith GD, Shepherd PR, Daniele N, Kulkarni S, Abbott B, Saylik D, Jones C, Lu L, Giuliano S, Hughan SC, Angus JA, Robertson AD, Salem HH (2005) PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 11:507-514
38. Kasirer-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, Shattil SJ (2004) Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood 103:3403-3411
39. Kim S, Mangin P, Dangelmaier C, Lillian R, Jackson SP, Daniel JL, Kunapuli SP (2009) Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets. J Biol Chem 284:33763-33772
40. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG (2000) The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrincoated pits. J Biol Chem 275:23120-23126
41. Lee SB, Rhee SG (1995) Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol 7:183-189
42. Li H, Chen Q, Moss AJ, Robinson J, Goytia V, Perry JC, Vincent GM, Priori SG, Lehmann MH, Denfield SW, Duff D, Kaine S, Shimizu W, Schwartz PJ, Wang Q, Towbin JA (1998) New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation 97:1264-1269
43. Li X, Zima AV, Sheikh F, Blatter LA, Chen J (2005a) Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1, 4, 5-trisphosphate (IP3)-receptor type 2-deficient mice. Circ Res 96:1274-1281
44. Li Y, Gamper N, Hilgemann DW, Shapiro MS (2005b) Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4, 5-bisphosphate. J Neurosci 25:9825-9835
45. Li Z, Zhang G, Feil R, Han J, Du X (2006) Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3. Blood 107:965-972
46. Li Y, Zaydman MA, Wu D, Shi J, Guan M, Virgin-Downey B, Cui J (2011) KCNE1 enhances phosphatidylinositol 4, 5-bisphosphate (PIP2) sensitivity of IKs to modulate channel activity. Proc Natl Acad Sci U S A 108:9095-9100
47. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
48. Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR (2010) PI3K (p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 30:724-732
49. Lopes CM, Zhang H, Rohacs T, Jin T, Yang J, Logothetis DE (2002) Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34:933-944
50. Loussouarn G, Park KH, Bellocq C, Baro I, Charpentier F, Escande D (2003) Phosphatidylinositol-4, 5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J 22:5412-5421
51. Ma D, Tang XD, Rogers TB, Welling PA (2007) An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway. J Biol Chem 282:5781-5789
52. Mackenzie L, Bootman MD, Laine M, Berridge MJ, Thuring J, Holmes A, Li WH, Lipp P (2002) The role of inositol 1, 4, 5-trisphosphate receptors in Ca (2+) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 541:395-409
53. Marks AR (2000) Cardiac intracellular calcium release channels: role in heart failure. Circ Res 87:8-11
54. Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP (2010) Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 115:2008-2013
55. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S (2003) Phosphoinositide 3-kinase (p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 100:12355-12360
56. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL (2007) Protective effects of exercise and phosphoinositide 3-kinase (p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 104:612-617
57. Mejillano M, Yamamoto M, Rozelle AL, Sun HQ, Wang X, Yin HL (2001) Regulation of apoptosis by phosphatidylinositol 4, 5-bisphosphate inhibition of caspases, and caspase inactivation of phosphatidylinositol phosphate 5-kinases. J Biol Chem 276:1865-1872
58. Myers DE, Fidge NH, Stanton H, Larkins RG (1992) The effects of low density lipoprotein and high density lipoprotein on phosphoinositide hydrolysis in bovine aortic endothelial cells. Atherosclerosis 92:9-16
59. Naga Prasad SV, Esposito G, Mao L, Koch WJ, Rockman HA (2000) Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 275:4693-4698
60. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, Rockman HA (2001) Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor sequestration kinase 1. A role in receptor. J Biol Chem 276:18953-18959
61. Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, Rockman HA (2002) Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 158:563-575
62. Nakayama H, Bodi I, Maillet M, De Santiago J, Domeier TL, Mikoshiba K, Lorenz JN, Blatter LA, Bers DM, Molkentin JD (2010) The IP3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ Res 107:659-666
63. Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, Mao L, Rockman HA (2003) Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112:1067-1079
64. Oliver D, Lien CC, Soom M, Baukrowitz T, Jonas P, Fakler B (2004) Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids. Science 304:265-270
65. Park KH, Piron J, Dahimene S, Merot J, Baro I, Escande D, Loussouarn G (2005) Impaired KCNQ1-KCNE1 and phosphatidylinositol-4, 5-bisphosphate interaction underlies the long QT syndrome. Circ Res 96:730-739
66. Pasquet JM, Bobe R, Gross B, Gratacap MP, Tomlinson MG, Payrastre B, Watson SP (1999) A collagen-related peptide regulates phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human platelets. Biochem J 342(Pt 1):171-177
67. Patrucco E, Notte A, Barberis L, Selvetella G, Maffei A, Brancaccio M, Marengo S, Russo G, Azzolino O, Rybalkin SD, Silengo L, Altruda F, Wetzker R, Wymann MP, Lembo G, Hirsch E (2004) PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118:375-387
68. Perino A, Ghigo A, Ferrero E, Morello F, Santulli G, Baillie GS, Damilano F, Dunlop AJ, Pawson C, Walser R, Levi R, Altruda F, Silengo L, Langeberg LK, Neubauer G, Heymans S, Lembo G, Wymann MP, Wetzker R, Houslay MD, Iaccarino G, Scott JD, Hirsch E (2011) Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110gamma. Mol Cell 42:84-95
69. Perrino C, Naga Prasad SV, Patel M, Wolf MJ, Rockman HA (2005) Targeted inhibition of betaadrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves betaadrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression. J Am Coll Cardiol 45:1862-1870
70. Perrino C, Naga Prasad SV, Noma T, Mao L, Yan Z, Kim HS, Smithies O, Rockman HA (2006) Intermittent pressure overload triggers hypertrophy- independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116:1547-1560
71. Perrino C, Schroder JN, Lima B, Villamizar N, Nienaber JJ, Milano CA, Naga Prasad SV (2007) Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure. Circulation 116:2571-2579
72. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George A L Jr, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptacek LJ (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105:511-519
73. Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, Medcalf RL, Ming Z, Head GA, Tan JW, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Lukoshkova EV, Dart AM, Jennings GL, McMullen JR (2009) Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol 175:998-1009
74. Proven A, Roderick HL, Conway SJ, Berridge MJ, Horton JK, Capper SJ, Bootman MD (2006) Inositol 1, 4, 5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J Cell Sci 119:3363-3375
75. Ragab A, Severin S, Gratacap MP, Aguado E, Malissen M, Jandrot-Perrus M, Malissen B, Ragab-Thomas J, Payrastre B (2007) Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC gamma 2 activation. Blood 110:2466-2474
76. Redfield MM (2002) Heart failure-an epidemic of uncertain proportions. N Engl J Med 347:1442-1444
77. Resink TJ, Tkachuk VA, Bernhardt J, Buhler FR (1992) Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler Thromb 12:278-285
78. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003) Cell migration: integrating signals from front to back. Science 302:1704-1709
79. Rockman HA, Koch WJ, Lefkowitz RJ (2002) Seven-transmembrane-spanning receptors and heart function. Nature 415:206-212
80. Ross R (1986) The pathogenesis of atherosclerosis-an update. N Engl J Med 314:488-500
81. Ross R (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804
82. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
83. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT (1996) Coassembly of K (V) LQT1 and minK (IsK) proteins to form cardiac I (Ks) potassium channel. Nature 384:80-83
84. Sasaki T, Sasaki J, Sakai T, Takasuga S, Suzuki A (2007) The physiology of phosphoinositides. Biol Pharm Bull 30:1599-1604
85. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95
86. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19:2537-2548
87. Stojanovic A, Marjanovic JA, Brovkovych VM, Peng X, Hay N, Skidgel RA, Du X (2006) A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem 281:16333-16339
88. Sui JL, Petit-Jacques J, Logothetis DE (1998) Activation of the atrial KACh channel by the betagamma subunits of G proteins or intracellular Na+ ions depends on the presence of phosphatidylinositol phosphates. Proc Natl Acad Sci U S A 95:1307-1312
89. Wang Y, Hill JA (2010) Electrophysiological remodeling in heart failure. J Mol Cell Cardiol 48:619-632
90. Woodcock EA, Kistler PM, Ju YK (2009) Phosphoinositide signalling and cardiac arrhythmias. Cardiovasc Res 82:286-295
91. Wu X, Zhang T, Bossuyt J, Li X, McKinsey TA, Dedman JR, Olson EN, Chen J, Brown JH, Bers DM (2006) Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitationtranscription coupling. J Clin Invest 116:675-682
92. Yang KC, Jay PY, McMullen JR, Nerbonne JM (2012) Enhanced cardiac PI3Kalpha signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure. Cardiovasc Res 93:252-262
93. Yap CL, Anderson KE, Hughan SC, Dopheide SM, Salem HH, Jackson SP (2002) Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha (IIb) beta (3). Blood 99:151-158
94. Yin H, Stojanovic A, Hay N, Du X (2008) The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood 111:658-665
95. Zima AV, Blatter LA (2004) Inositol-1, 4, 5-trisphosphate-dependent Ca (2+) signalling in cat atrial excitation-contraction coupling and arrhythmias. J Physiol 555:607-615
96. Zolles G, Klocker N, Wenzel D, Weisser-Thomas J, Fleischmann BK, Roeper J, Fakler B (2006) Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron 52:1027-1036